Repeatability of Electroretinogram and Visual Evoked Potential

Retinal Disease Clinical Trial

Official title:

Repeatability of Electroretinogram and Visual Evoked Potential in Clinical Practice

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05334875
• Other study ID #: RC 8-22
• Status: Recruiting
• Phase: N/A
• Start date: April 1, 2022
• Est. completion date: October 30, 2022

Study information

• Verified date: April 2022
• Source: Benha University
• Contact: Ahmed Abdelshafy, MD
• Phone: 01222328766
• Email: ahmad4lg[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To assess repeatability of electroretinogram and visual evoked potential in clinical practice

Description:

To assess repeatability of electroretinogram in evaluation of retinal function and visual evoked potential in evaluation of visual pathway in clinical practice.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 250
• Est. completion date: October 30, 2022
• Est. primary completion date: October 30, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Normal subjects visit banha university hospital seeking regular checkup and subjects asked for ERG and VEP as a pre-occupational examination.

Exclusion Criteria:

• Patients previously diagnosed with any retinal disease or visual pathway disease that may affect ERG and VEP tests.

Related Conditions & MeSH terms

• Retinal Disease
• Retinal Diseases
• Vision Disorders
• Vision, Low
• Visual Impairment

Intervention

Diagnostic Test:
• Electroretinogram (ERG)
Applying electrodes to assess retinal function
• Visual evoked potential (VEP)
Applying electrodes to assess visual pathway function

Locations

Country	Name	City	State
Egypt	Ahmed Abdelshafy Tabl	Banha	Benha

Sponsors (1)

Lead Sponsor	Collaborator
Benha University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Repeatability of VEP amplitude.	VEP amplitude measured in nano volt (nV).	Changes from baseline measurements and at one week.
Other	Repeatability of VEP latency.	Latency of VEP measured by millisecond (msec).	Changes from baseline measurements and at one week.
Primary	Repeatability of ERG amplitude.	ERG amplitude measured in nano volt (nV).	Changes from baseline measurements and at one week.
Secondary	Repeatability of ERG latency.	Latency of ERG measured by millisecond (msec).	Changes from baseline measurements and at one week.